The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer | Zendy

Saya Jacob | Zendy; Andrew A. Davis | Zendy; Lorenzo Gerratana | Zendy; Marko Velimirovic | Zendy; Ami N. Shah | Zendy; Firas Wehbe | Zendy; Neelima Katam | Zendy; Qiang Zhang | Zendy; Lisa Flaum | Zendy; Kalliopi P. Siziopikou | Zendy; Leonidas C. Platanias | Zendy; William J. Gradishar | Zendy; Amir Behdad | Zendy; Aditya Bardia | Zendy; Massimo Cristofanilli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer

Author(s) -

Saya Jacob,

Andrew A. Davis,

Lorenzo Gerratana,

Marko Velimirovic,

Ami N. Shah,

Firas Wehbe,

Neelima Katam,

Qiang Zhang,

Lisa Flaum,

Kalliopi P. Siziopikou,

Leonidas C. Platanias,

William J. Gradishar,

Amir Behdad,

Aditya Bardia,

Massimo Cristofanilli

Publication year - 2021

Publication title -

clinical cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.427

H-Index - 324

eISSN - 1557-3265

pISSN - 1078-0432

DOI - 10.1158/1078-0432.ccr-20-1566

Subject(s) - metastatic breast cancer , medicine , breast cancer , cancer , circulating tumor dna , pathology , oncology , cancer research

Circulating tumor DNA (ctDNA) is a promising tool for noninvasive longitudinal monitoring of genomic alterations. We analyzed serial ctDNA to characterize genomic evolution in progressive metastatic breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore